Wednesday, 13 Dec 2017

Biologic/Novel Rx

Datesort ascending Type Title Save
11 Sep 2017 News Jak Inhibition May Ameliorate Pruritus
08 Sep 2017 News Biologic Use in Adult-Onset Still's Disease
07 Sep 2017 Social An approved biosimilar by regulatory authorities neither better nor worse in efficacy/safety to its bio-originator. https://t.co/cxWtoUsmwW
07 Sep 2017 News New Recommendations on Biosimilar Use
07 Sep 2017 Social In 10yrs MTX/biologic use increased (40%/1.7% to 64%/27%) & rate of ortho surgery dropped (72 to 51/1000 pts in 2014 https://t.co/IE72n2YMPB
06 Sep 2017 Social US patent office has issued two patents for janus kinase(JaK) inhibitors for hair loss. https://t.co/TReKaoFUwy
30 Aug 2017 News Turnabout for Baricitinib
29 Aug 2017 Social 25 studies shows low risk of HBV reactivation (1.6%) w/ resolved HBV - not changed by TNFi, other biologics, DMARDs https://t.co/wzjikRHPFh
28 Aug 2017 Social Severe (ocular) Behcets study: ~half respond to TNF inhib but only half these stay in remission w/ TNFi withdrawal https://t.co/a2oGZADlle
28 Aug 2017 News Canakinumab Reduces CV Outcomes in High Risk Patients
28 Aug 2017 Social RT @DanielHSolomon: Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease — NEJM how will this affect rheumatology? https:/…
22 Aug 2017 Social RT @RheumKay: What's harder than making copycat biotech drugs? Selling them https://t.co/gMHACs9RpN via @markets
22 Aug 2017 Social Korean companies Celltrion & Samsung Bioepis have exported $1.63 Billion in Biosimilars in 2016. https://t.co/JHBQqJSV6h
21 Aug 2017 Social Ironwood announces FDA approval of its combo drug lesinurad/allopurinol in a 200/300 tablet. Could this be useful? https://t.co/lcUZTieKqg
21 Aug 2017 Social FDA CDER list of licensed biologics and biosimilars updated Aug 2017 https://t.co/bIFmjPsId7
19 Aug 2017 Social RheumNow Wk in Review up! How to store enbrel, over/under testing. Check out podcast https://t.co/I5b8tFK7Oa video https://t.co/rJ2nMY6woD
14 Aug 2017 Social Tocilizumab in Scleroderma completed enrollment in phase III trial - another yr till skin + lung results https://t.co/6QVGeDScbv
08 Aug 2017 Social Tanezumab (MAb against nerve growth factor) is being fast-tracked by FDA as a non-opioid pain reliever. https://t.co/ZXJnS7CmE4
08 Aug 2017 News Therapeutic Update: 5 Questions on Sirukumab FDA Hearing
06 Aug 2017 Social When biosimilars are available, when will you prescribe them?